questionText: To ask the Secretary of State for Health and Social Care, whether she is taking steps to support (a) NICE and (b) NHS England to apply flexibility to appraisal of combination medicines; and whether flexibility will be applied in NICE appraisals for multiple myeloma.
answerText: The Competition and Markets Authority (CMA) published a statement in November 2023 that clarifies the circumstances under which it will not prioritise enforcement action against drug firms when they implement a specific negotiation framework, to make more...
heading: Multiple Myeloma: Drugs